Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lalji Gediya

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Medicinal Chemistry (Shariqah (United Arab Emirates))|July 20, 2006
Retinoids in clinical useVincent C O Njar, Lalji Gediya, Puranik Purushottamachar, et al.
Oncotarget|January 22, 2015
Simultaneous targeting of androgen receptor (AR) and MAPK-interacting kinases (MNKs) by novel retinamides inhibits growth of human prostate cancer cell linesVidya P Ramamurthy, Senthilmurugan Ramalingam, Lalji Gediya, et al.
Oncotarget|February 8, 2014
First MNKs degrading agents block phosphorylation of eIF4E, induce apoptosis, inhibit cell growth, migration and invasion in triple negative and Her2-overexpressing breast cancer cell linesSenthilmurugan Ramalingam, Lalji Gediya, Andrew K Kwegyir-Afful, et al.
Bioorganic & Medicinal Chemistry|March 15, 2006
Retinoic acid metabolism blocking agents (RAMBAs) for treatment of cancer and dermatological diseasesVincent C O Njar, Lalji Gediya, Puranik Purushottamachar, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Medicinal Chemistry (Shariqah (United Arab Emirates))|July 20, 2006
Retinoids in clinical useVincent C O Njar, Lalji Gediya, Puranik Purushottamachar, et al.
Oncotarget|January 22, 2015
Simultaneous targeting of androgen receptor (AR) and MAPK-interacting kinases (MNKs) by novel retinamides inhibits growth of human prostate cancer cell linesVidya P Ramamurthy, Senthilmurugan Ramalingam, Lalji Gediya, et al.
Oncotarget|February 8, 2014
First MNKs degrading agents block phosphorylation of eIF4E, induce apoptosis, inhibit cell growth, migration and invasion in triple negative and Her2-overexpressing breast cancer cell linesSenthilmurugan Ramalingam, Lalji Gediya, Andrew K Kwegyir-Afful, et al.
Bioorganic & Medicinal Chemistry|March 15, 2006
Retinoic acid metabolism blocking agents (RAMBAs) for treatment of cancer and dermatological diseasesVincent C O Njar, Lalji Gediya, Puranik Purushottamachar, et al.
Pageof 1